These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer. Jain KS, Sikora AG, Baxi SS, Morris LG. Cancer; 2013 May 15; 119(10):1832-7. PubMed ID: 23423883 [Abstract] [Full Text] [Related]
7. Oral sex and human papilloma virus-related head and neck squamous cell cancer: a review of the literature. Shah A, Malik A, Garg A, Mair M, Nair S, Chaturvedi P. Postgrad Med J; 2017 Nov 15; 93(1105):704-709. PubMed ID: 28778951 [Abstract] [Full Text] [Related]
9. [Human papilloma virus in head and neck cancer]. Barry B, Ortholan C. Cancer Radiother; 2014 Oct 15; 18(5-6):430-3. PubMed ID: 25151649 [Abstract] [Full Text] [Related]
10. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma. Oguejiofor KK, Hall JS, Mani N, Douglas C, Slevin NJ, Homer J, Hall G, West CM. Clin Oncol (R Coll Radiol); 2013 Nov 15; 25(11):630-8. PubMed ID: 23916365 [Abstract] [Full Text] [Related]
11. The interplay between HPV and host immunity in head and neck squamous cell carcinoma. Andersen AS, Koldjaer Sølling AS, Ovesen T, Rusan M. Int J Cancer; 2014 Jun 15; 134(12):2755-63. PubMed ID: 23913554 [Abstract] [Full Text] [Related]
12. The molecular mechanism of human papillomavirus-induced carcinogenesis in head and neck squamous cell carcinoma. Sano D, Oridate N. Int J Clin Oncol; 2016 Oct 15; 21(5):819-826. PubMed ID: 27339270 [Abstract] [Full Text] [Related]
14. Prevalence of human papillomavirus types, viral load and physical status of HPV16 in head and neck squamous cell carcinoma from the South Swedish Health Care Region. Faust H, Eldenhed Alwan E, Roslin A, Wennerberg J, Forslund O. J Gen Virol; 2016 Nov 15; 97(11):2949-2956. PubMed ID: 27667722 [Abstract] [Full Text] [Related]
15. Clinical features and treatment strategy for HPV-related oropharyngeal cancer. Okami K. Int J Clin Oncol; 2016 Oct 15; 21(5):827-835. PubMed ID: 27380170 [Abstract] [Full Text] [Related]
16. Changing trends in human papillomavirus-associated head and neck squamous cell carcinoma. Wang XI, Thomas J, Zhang S. Ann Diagn Pathol; 2012 Jan 15; 16(1):7-12. PubMed ID: 22001331 [Abstract] [Full Text] [Related]
17. Human papillomavirus and head and neck squamous cell carcinoma: recent evidence and clinical implications. Hennessey PT, Westra WH, Califano JA. J Dent Res; 2009 Apr 15; 88(4):300-6. PubMed ID: 19407148 [Abstract] [Full Text] [Related]
18. [Research progress in pathogenesis, treatment and prognosis of HPV positive head and neck squamous cell carcinoma]. Shui CY, Li C, Liu W, Cai YC, Jiang J, Sun RH, Zhou YQ, Qin G. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May 07; 53(5):392-396. PubMed ID: 29764025 [Abstract] [Full Text] [Related]
19. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. Gillison ML, D'Souza G, Westra W, Sugar E, Xiao W, Begum S, Viscidi R. J Natl Cancer Inst; 2008 Mar 19; 100(6):407-20. PubMed ID: 18334711 [Abstract] [Full Text] [Related]
20. Clinico-pathological peculiarities of human papilloma virus driven head and neck squamous cell carcinoma: A comprehensive update. Devaraja K, Aggarwal S, Verma SS, Gupta SC. Life Sci; 2020 Mar 15; 245():117383. PubMed ID: 32007572 [Abstract] [Full Text] [Related] Page: [Next] [New Search]